Related Experiment Videos
Side effects of short course tuberculosis chemotherapy
The Medical Journal of Malaysia
|March 1, 1991
Summary
A study of 300 tuberculosis patients found that 38.7% experienced side effects from short-course chemotherapy. Nine percent required treatment modifications due to severe adverse events, highlighting the need for managing chemotherapy side effects.
Area of Science:
- Pulmonology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Short-course chemotherapy (SCC) is a standard TB treatment.
- Managing treatment side effects is crucial for patient adherence and outcomes.
Purpose of the Study:
- To identify patient characteristics associated with side effects in TB patients.
- To determine the incidence of side effects during SCC.
- To explore modifications for minimizing treatment-related adverse events.
Main Methods:
- Retrospective study design.
- Analysis of 300 tuberculosis patients registered in 1985.
- Data collection on patient demographics and treatment regimens.
Main Results:
- 116 out of 300 patients (38.7%) experienced side effects.
- 27 patients (9%) had severe side effects necessitating treatment regimen changes.
- Common side effects and their impact on treatment were observed.
Conclusions:
- Side effects are common in short-course tuberculosis chemotherapy.
- A significant proportion of patients require treatment modification due to adverse events.
- Strategies for minimizing and managing side effects are essential for effective TB treatment.